Authors: | Shah, P. D.; Moynahan, M. E.; Modi, S.; Hamilton, N.; Caravella, B. A.; Zamora, S.; Dang, C.; Gilewski, T.; Traina, T.; Comen, E.; Sugarman, S. M.; D'Andrea, G.; Lake, D.; Goldfarb, S.; Patil, S.; Covey, A.; Berger, M.; Lacouture, M.; Norton, L.; Hudis, C. A.; Baselga, J.; Chandarlapaty, S.; Dickler, M. |
Abstract Title: | Phase I study of PI3Kα inhibitor BYL719 + aromatase inhibitor (AI) in patients (pts) with hormone receptor-positive (HR+) metastatic breast cancer (MBC) |
Meeting Title: | 106th Annual Meeting of the American Association for Cancer Research (AACR) |
Journal Title: | Cancer Research |
Volume: | 75 |
Issue: | 15 Suppl. |
Meeting Dates: | 2015 Apr 18-22 |
Meeting Location: | Philadelphia, PA |
ISSN: | 0008-5472 |
Publisher: | American Association for Cancer Research |
Date Published: | 2015-08-01 |
Language: | English |
ACCESSION: | WOS:000371597100101 |
DOI: | 10.1158/1538-7445.am2015-ct330 |
PROVIDER: | wos |
Notes: | Meeting Abstract: CT330 -- 106th Annual Meeting of the American-Association-for-Cancer-Research (AACR) -- APR 18-22, 2015 -- Philadelphia, PA -- Source: Wos |